SCHEMBL8186149

SCHEMBL8186149

O=C1CCC(N2CCNCC2Cc2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 10/20 0.53
SLC6A4 P31645 10/20 0.53
SLC6A3 Q01959 10/20 0.53
CHIT1 Q13231 2/20 0.44
CHIA Q9BZP6 2/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA4 P22748 2/20 0.43
CA9 Q16790 2/20 0.43
MITF O75030 1/20 0.42
HTR2A P28223 2/20 0.41
HTR2C P28335 2/20 0.41
HTR2B P41595 2/20 0.41
CYP2D6 P10635 1/20 0.41
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9727457 0.74 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL3724429 0.71 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3MITF
SCHEMBL4237634 0.71 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3MITF
SCHEMBL10413244 0.71 SLC6A2 (0.65) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL6926417 0.71 SLC6A2 (0.65) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL14920544 0.71 SLC6A4 (0.65) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL22285003 0.71 SLC6A2 (0.65) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL29022140 0.71 SLC6A2 (0.65) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL10388380 0.71 SLC6A4 (0.60) SLC6A2SLC6A4SLC6A3CA1CA2
SCHEMBL3447412 0.71 SLC6A4 (0.60) SLC6A2SLC6A4SLC6A3CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6153611-A AS NON-DOPAMINERGIC ANTIISCHEMIC COMPOUNDS FOR TREATING BRAIN DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-28 US disclosed